Alira Health Joins EMIG to Advance Market Access in the UK

News
Published on:
April 5, 2023

We are pleased to announce that Alira Health has joined the Ethical Medicines Industry Group (EMIG), a multi-stakeholder network and trade association that represents the interests of life sciences companies in the UK.

The growth and sustainability of the UK health ecosystem is critical to providing patients with access to quality care, and that ecosystem growth is central to EMIG’s mission. At Alira Health, we put patients at the centre of everything we do."
Richard Charter Vice President MedTech Market Access, Europe & Asia Pacific

EMIG represents its over 300 industry members and associate members to government, the NHS, regulatory bodies, and academic research organisations in order to ensure that patients are able to access a wide range of innovative medicines. And EMIG encompasses the breadth of the health and medicines ecosystem in the UK, which makes it a vital platform for greater knowledge and ideas exchange. Alira Health’s access to this platform strengthens our ability to serve our clients in the UK while advancing our global market access solutions.

“The growth and sustainability of the UK health ecosystem is critical to providing patients with access to quality care, and that ecosystem growth is central to EMIG’s mission. At Alira Health, we put patients at the centre of everything we do. Working with EMIG aligns us with a valuable source of expertise and knowledge that will benefit our clients as we work together to get much-needed products to patients in the UK market,” said Richard Charter, Vice President MedTech Market Access – Europe & Asia Pacific.

Membership in EMIG will enable Alira Health to stay current on new UK developments and those on the horizon and to better prepare our clients for challenges and opportunities ahead in the UK market.

This news follows on the heels of Alira Health’s partnership with leading UK market access specialist consultancy Policy Matters, as we further align with resources for the complex and challenging UK market.

Related news

Events April 10, 2024
European Patients as Partners in Clinical Research 2024
Join our panel at the European Patients as Partners event: "The Impact of Patient Involvement Along the Product Lifecycle."
Patient Centricity Patient Engagement
Case Studies March 26, 2024
Pharma Company Overcomes Launch Challenges with Patient-Centric Strategy
Our patient engagement team helped this pharma client identify the drivers behind the challenges they faced with their product launch.
Patient Centricity Patient Engagement Pharma
Blog March 18, 2024
WHO Model Lists of Essential Medicines: What You Need to Know 
Our Market Access experts share the importance of the EML for pharma companies and four best practices for a successful application, based on our extensive experience in interactions with the WHO.
Market Access
Blog March 13, 2024
Strategic Patient Engagement as a Game Changer for Your Product Success
This FAQ addresses popular questions about how to make patient engagement the core of a product development and commercialization strategy.
Patient Centricity Patient Engagement
Case Studies March 12, 2024
Pharma Company Adopts a Patient-Centric Value Proposition for Regulatory and Payer Dossier
A pharma company had a wealth of patient data on a product in development and they wanted to create a long-term strategy that would create a continuity of patient engagement across(...)
Patient Centricity Patient Engagement Pharma
Events February 20, 2024
World EPA Congress Europe
Look for market access and pricing experts Ahmad Bechara and Andrea Mantovani representing Alira Health on the agenda at World EPA Congress.
Market Access Pricing Real-World Evidence (RWE)
News January 24, 2024
Alira Health and AseBio Announce Market Access Mentoring Program for 2024
Alira Health and AseBio, the Spanish Bioindustry Association, are pleased to announce the 2024 edition of their market access mentoring program for AseBio members.
Biotech Market Access Spain Startups
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.